Ching‐Chi Lee

Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC Matters

Nan–Yao Lee, Ching‐Chi Lee, Wei-Han Huang et al. · Clinical Infectious Diseases · 2012 · 170 citations

Pneumocystis jiroveci pneumonia in immunocompromised patients: Delayed diagnosis and poor outcomes in non-HIV-infected individuals

Ming-Chi Li, Nan–Yao Lee, Ching‐Chi Lee et al. · Journal of Microbiology Immunology and Infection · 2012 · 133 citations

Poor Outcomes, Pneumocystis Jiroveci Pneumonia, Non-hiv-infected Individuals +4

Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia

Ching‐Chi Lee, Chung-Hsun Lee, Ming‐Yuan Hong et al. · Critical Care · 2017 · 106 citations · Full text

Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?

Yuan‐Pin Hung, Jen‐Chieh Lee, Chun-Wei Chiu et al. · Antibiotics · 2022 · 94 citations · Full text

Molnupiravir—A Novel Oral Anti-SARS-CoV-2 Agent

Ching‐Chi Lee, Chih‐Chia Hsieh, Wen‐Chien Ko · Antibiotics · 2021 · 85 citations · Full text

Viral Diagnostics, Emerging Infectious Diseases, Neurovirology +12